118 related articles for article (PubMed ID: 3575350)
1. Comparison of 3H-spiperone binding in caudate nuclei of rabbits and rats.
Hernandez LL; Powell DA
Pharmacol Biochem Behav; 1987 Feb; 26(2):253-8. PubMed ID: 3575350
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
Watling KJ; Iversen LL
J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
[TBL] [Abstract][Full Text] [Related]
3. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--III. The effects of lesions in the parafascicular-intralaminar nuclei on D2 dopamine receptors and high affinity dopamine uptake.
Kilpatrick IC; Jones MW; Pycock CJ; Riches I; Phillipson OT
Neuroscience; 1986 Nov; 19(3):991-1005. PubMed ID: 2948134
[TBL] [Abstract][Full Text] [Related]
4. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
Withy RM; Mayer RJ; Strange PG
J Neurochem; 1981 Nov; 37(5):1144-54. PubMed ID: 7299393
[TBL] [Abstract][Full Text] [Related]
5. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
Battaglia G; Titeler M
Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
[TBL] [Abstract][Full Text] [Related]
6. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
Leslie CA; Bennett JP
Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
[TBL] [Abstract][Full Text] [Related]
7. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
Köhler C; Karlsson-Boethius G
J Neural Transm; 1988; 73(2):87-100. PubMed ID: 2974879
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
Lehmann J; Briley M; Langer SZ
Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
[TBL] [Abstract][Full Text] [Related]
9. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
Near JA; Mahler HR
J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
[No Abstract] [Full Text] [Related]
11. Evidence for the importance of a carboxyl group in the binding of ligands to the D2 dopamine receptor.
Williamson RA; Strange PG
J Neurochem; 1990 Oct; 55(4):1357-65. PubMed ID: 2144583
[TBL] [Abstract][Full Text] [Related]
12. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
Beart PM; Krstich M; McDonald D; Gundlach AL
Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
[TBL] [Abstract][Full Text] [Related]
13. Multiple receptors for brain dopamine.
Titeler M; Weinreich P; Sinclair D; Seeman P
Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
[TBL] [Abstract][Full Text] [Related]
14. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
Titeler M
Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
[No Abstract] [Full Text] [Related]
15. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
17. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
Altar CA; Kim H; Marshall JF
J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
[TBL] [Abstract][Full Text] [Related]
18. Effect of iron chelators on dopamine D2 receptors.
Ben-Shachar D; Finberg JP; Youdim MB
J Neurochem; 1985 Oct; 45(4):999-1005. PubMed ID: 2993525
[TBL] [Abstract][Full Text] [Related]
19. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
Wreggett KA; Seeman P
Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
[TBL] [Abstract][Full Text] [Related]
20. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
